HUMAN PAPILLOMA VIRUS INFECTION TYPE 16
Clinical trials for HUMAN PAPILLOMA VIRUS INFECTION TYPE 16 explained in plain language.
Never miss a new study
Get alerted when new HUMAN PAPILLOMA VIRUS INFECTION TYPE 16 trials appear
Sign up with your email to follow new studies for HUMAN PAPILLOMA VIRUS INFECTION TYPE 16, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine aims to reverse HPV-Linked cervical changes without surgery
⭐️ VACCINE ⭐️ Recruiting nowThis phase 2 trial tests a DNA vaccine called PVX4 in 138 women with HPV16-related high-grade cervical dysplasia (CIN2/3). The vaccine is given as a shot with a small electrical pulse to help it enter cells. The goal is to see if it can clear the virus and make abnormal cervical …
Matched conditions: HUMAN PAPILLOMA VIRUS INFECTION TYPE 16
Phase: PHASE2 • Sponsor: PapiVax Biotech, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:29 UTC
-
Can a vaccine and a urine test tame HPV16?
Disease control Recruiting nowThis study is testing whether the Gardasil 9 vaccine can reduce the infectivity of HPV16 virus in women who already have the infection. About 50 women aged 18-45 will receive two doses of the vaccine, and researchers will use urine samples to measure virus activity and immune res…
Matched conditions: HUMAN PAPILLOMA VIRUS INFECTION TYPE 16
Phase: PHASE2 • Sponsor: Universiteit Antwerpen • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC